Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Therapeutic Drug Monitoring Market Today And What Is Its Future Size?

The market size for therapeutic drug monitoring has seen significant growth recently. Projections indicate an increase from $2.23 billion in 2024 to $2.41 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. The growth in the past period can be credited to an increase in cases of chronic illnesses, concerns about drug safety, the inclusion of pharmacogenomics, growth in drug development, and regulations focusing on precision medicine.

Over the coming years, we can anticipate swift expansion in the therapeutic drug monitoring market. By 2029, the industry expects to reach $3.67 billion, showing a compound annual growth rate (CAGR) of 11.1%. This robust growth during the forecast period can be largely attributed to broader applications in oncology, a surge in customised medicine practices, a global rise in the aged population, growth of point-of-care testing, and escalated pharmaceutical R&D expenditure. The period under forecast will be marked by certain trends such as personalized medicine, technological progression, inflated drug discovery and utilisation, point-of-care testing or POCT, and the emergence of new biomarkers and assay technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

What External And Internal Drivers Are Influencing The Therapeutic Drug Monitoring Market?

The burgeoning number of organ transplant procedures is anticipated to fuel the expansion of the therapeutic drug monitoring market. Organ transplantation refers to a surgical procedure that moves an organ from one person, the donor, to another person. Therapeutic drug monitoring (TDM) of immunosuppressive drugs is recognized as an effective strategy for managing patients who have undergone solid organ transplantation. TDM optimization could help avert the potentially harmful effects of overly toxic or insufficiently low-dose therapy, which could lead to organ rejection. For instance, a report published by the United Network for Organ Sharing, a non-profit organization in the USA that oversees organ transplants, noted that in 2022, 42,887 organ transplants took place in the USA, marking a 3.7% rise from 2021. Consequently, the increase in organ transplant surgeries is a key driver for the therapeutic drug monitoring market.

How Is The Therapeutic Drug Monitoring Market Categorized Across Applications And Types?

The therapeutic drug monitoringmarket covered in this report is segmented –

1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors

2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms

3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs

4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

Subsegments:

1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards

2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment

3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers

4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques

How Are Market Trends Influencing Competition In The Therapeutic Drug Monitoring Market?

Key players in the therapeutic drug monitoring market are shifting their focus towards the advancement of anti-idiotypic antibody technology. This move aims to improve the sensitivity and specificity of assays devoted to accurately gauging biologic drug levels and evaluating patient immune reactions. The technology is instrumental in therapeutic drug monitoring as it enables the correct detection and quantification of biologic drug levels, guarantees appropriate dosage, and tracks patient immune responses. For example, Bio-Rad Laboratories, a biotechnology firm based in the US, unveiled new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies for bioanalytical assays in June 2024, enhancing pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These novel antibodies augment the dependability of assays for antibody-drug conjugates (ADCs) and are a vital component in the therapeutic drug monitoring market, facilitating precise evaluations of drug levels and immune reactions for the best dosage management in patients.

Who Are The Global Leaders Steering The Therapeutic Drug Monitoring Market Forward?

Major companies operating in the therapeutic drug monitoring market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

What Are The Emerging Regional Trends Driving The Therapeutic Drug Monitoring Market?

North America was the largest region in the therapeutic drug monitoring market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10069&type=smp

Browse Through More Reports Similar to the Global Therapeutic Drug Monitoring Market 2025, By The Business Research Company

Operating Room Equipment Market 2025

https://www.thebusinessresearchcompany.com/report/operating-room-equipment-market

Anesthesia Disposables Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anesthesia-disposables-global-market-report

Veterinary Anesthesia Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anesthesia-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model